Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine

Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine

Sabine Lindquist, Martin StangelSection Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, GermanyAbstract: In Lambert–Eaton myasthenic syndrome (LEMS), antibodies against presynaptic voltage-gated calcium channels reduce the quanta...

Full description

Bibliographic Details
Main Authors: Lindquist S, Stangel M
Format: Article
Language:English
Published: Dove Medical Press 2011-05-01
Series:Neuropsychiatric Disease and Treatment
Online Access:http://www.dovepress.com/update-on-treatment-options-for-lambertndasheaton-myasthenic-syndrome--a7547

Similar Items

Similar Items